As of 2026-02-07, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (3.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.18 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -374.3%.
The range of the Relative Valuation is (2.78) - (3.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 26.2x | 23.0x |
| Forward P/E multiples | 22.3x - 35.9x | 29.1x |
| Fair Price | (2.78) - (3.25) | (3.24) |
| Upside | -335.3% - -375.7% | -374.3% |
| Date | P/E |
| 2026-02-05 | -9.49 |
| 2026-02-04 | -10.21 |
| 2026-02-03 | -10.29 |
| 2026-02-02 | -10.05 |
| 2026-01-30 | -9.33 |
| 2026-01-29 | -11.58 |
| 2026-01-28 | -12.06 |
| 2026-01-27 | -13.75 |
| 2026-01-26 | -12.62 |
| 2026-01-23 | -13.67 |
| 2026-01-22 | -14.15 |
| 2026-01-21 | -12.54 |
| 2026-01-20 | -10.53 |
| 2026-01-16 | -11.01 |
| 2026-01-15 | -10.29 |
| 2026-01-14 | -9.97 |
| 2026-01-13 | -9.65 |
| 2026-01-12 | -9.49 |
| 2026-01-09 | -9.41 |
| 2026-01-08 | -9.49 |
| 2026-01-07 | -9.41 |
| 2026-01-06 | -9.17 |
| 2026-01-05 | -9.17 |
| 2026-01-02 | -9.17 |
| 2025-12-31 | -9.25 |
| 2025-12-30 | -9.25 |
| 2025-12-29 | -9.41 |
| 2025-12-26 | -9.89 |
| 2025-12-24 | -9.89 |
| 2025-12-23 | -9.73 |
| 2025-12-22 | -9.81 |
| 2025-12-19 | -9.41 |
| 2025-12-18 | -9.49 |
| 2025-12-17 | -9.25 |
| 2025-12-16 | -9.65 |
| 2025-12-15 | -9.89 |
| 2025-12-12 | -10.45 |
| 2025-12-11 | -10.61 |
| 2025-12-10 | -10.61 |
| 2025-12-09 | -10.53 |
| 2025-12-08 | -11.18 |
| 2025-12-05 | -11.26 |
| 2025-12-04 | -11.42 |
| 2025-12-03 | -11.26 |
| 2025-12-02 | -10.77 |
| 2025-12-01 | -10.93 |
| 2025-11-28 | -11.50 |
| 2025-11-26 | -11.50 |
| 2025-11-25 | -11.34 |
| 2025-11-24 | -11.42 |